OLR1 and myocardial infarction: Inoue and coworkers found no association between sLOX-1 and risk of myocardial infarction in a population cohort involving 2295 subjects aged 30-79 years, whereas an association of borderline significance was observed using an index including both sLOX-1 and LOX-1 ligands containing apolipoprotein B [18].